Lexaria Bioscience (LEXX) Q1 2025 Earnings
LEXX·Reported April 14, 2025·Before market open
Lexaria Bioscience reported Q1 2025 revenue of $174.0K, beat analyst consensus of $91.3K by $82.7K. Diluted EPS came in at $-0.15, beat the $-0.16 consensus by $0.01.
Revenue
$174.0Kbeat by $82.7K
Consensus: $91.3KDiluted EPS
$-0.15beat by $0.01
Consensus: $-0.16
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about Lexaria Bioscience's Q1 2025 earnings report.
Lexaria Bioscience (LEXX) reported Q1 2025 earnings on April 14, 2025 before market open.
Lexaria Bioscience reported revenue of $174.0K and diluted EPS of $-0.15 for Q1 2025.
Revenue beat the consensus estimate of $91.3K by $82.7K. EPS beat the consensus estimate of $-0.16 by $0.01.
You can read the 10-Q periodic report (0001640334-25-000629) directly on SEC EDGAR. The filing index links above go to sec.gov.